Abstract: Objective Sevoflurane is widely used in pediatric anesthesia and former studies showed that it causes neurodegeneration in the developing brain. The present study was carried out to investigate the effects of sevoflurane on neurogenesis, neurodegeneration and behavior. Methods We administered 5-bromodeoxyuridine, an S-phase marker, before, during, and after 4 h of sevoflurane given to rats on postnatal day 7 to assess dentate gyrus progenitor proliferation and Fluoro-Jade staining for degeneration. Spatial reference memory was tested 2 and 6 weeks after anesthesia. Results Sevoflurane decreased progenitor proliferation and increased cell death until at least 4 days after anesthesia. Spatial reference memory was not affected at 2 weeks but was affected at 6 weeks after sevoflurane administration. Conclusion Sevoflurane reduces neurogenesis and increases the death of progenitor cells in developing brain. This might mediate the lateonset neurocognitive outcome after sevoflurane application.
Introduction
Recent studies show that anesthetic agents are toxic to the developing brain and that this injury results in longterm impairment of cognitive function. Such neurotoxicity has now been demonstrated not only for isoflurane [1] but also for ketamine [2] , midazolam [2] , diazepam, pentobarbital [3] , thiopental [4] , N 2 O [5] and propofol [4, [6] [7] [8] . Pregnant women, newborns, and infants are often exposed to anesthetic agents during childbirth or for surgical procedures.
The administration of anesthetics often occurs during an important period of brain growth, the growth-spurt, ranging from the last 3 months of pregnancy until ~2 years after birth in humans or during the first 2 weeks after birth in rodents [9] [10] [11] [12] . Therefore, it is important to study the mechanisms underlying the deleterious effects of these agents on the developing nervous system during this critical period.
Although the widely-recognized neurotoxic effect of anesthesia is neonatal brain cell death, recent studies suggest that cell death after a certain anesthetic agent such as isoflurane by itself is insufficient to cause neurocognitive dysfunction [13] . If cell death was directly responsible for cognitive impairment, one would expect compromised neurobehavioral activity immediately after neuronal loss followed by gradual improvement. However, although cell death occurs immediately after isoflurane exposure, cognitive deficits do not become apparent until 4-6 weeks later [5, 13, 14] . It has therefore been suggested that anesthesia also impairs neurogenesis [13] and this may indeed contribute to anesthesia-induced neurocognitive dysfunction in rats.
The developing brain has a high degree of plasticity.
In rats at postnatal day 7 (P7), cell birth is a very common event. Neurogenesis occurs during development and persists in adulthood in the subventricular zone and the hippocampal dentate gyrus (DG). The peak of DG neuronal expansion occurs around P7 [15] . Appropriate neurogenesis in the DG is crucial to hippocampus-dependent episodic learning and memory. Any intervention that affects this process could result in impaired hippocampal learning [16, 17] .
fluoromethylether) is one of the most frequently used volatile anesthetics during surgery and cesarean delivery because of its low blood-gas partition coefficient and low pungency. It is especially useful for infants and children because of its properties of rapid induction and recovery together with less irritation to the airway [14, 18] . It has been recently shown that neonatal exposure to sevoflurane causes learning disabilities [14] . In this study, we tested the hypothesis that sevoflurane induces acute brain cell death and decreases progenitor proliferation in P7 rats, and that the impaired neurogenesis in the DG causes the delayed onset of neurocognitive deficits in these animals.
Material and methods

Surgeries
Male Sprague Dawley rats at P7 were placed in an acrylic box. The room temperature was maintained at 25°C by an air-conditioner [14] . The rats were anesthetized in groups of six at 1 minimum alveolar concentration for 4 h and confirmed by tail clamping. Movement was defined as any movement other than breathing.
Tail clamping with an alligator clamp was repeated every 30 min from the induction of general anesthesia. In the pilot study, we established that sevoflurane concentrations between 3% and 5% maintained a sufficient depth of anesthesia, as determined by 50% of mice lacking a reaction to a painful stimulus (tail clamping). The concentrations of sevoflurane are similar to those used by others [19] . to target the processes of progenitor proliferation. The rats were divided into three groups according to the time of injection. In group I, 300 mg/kg BrdU was injected 4 h before anesthesia. In group II, 300 mg/kg BrdU was injected immediately before anesthesia. In group III, 50 mg/kg BrdU was injected 4 days after anesthesia twice at a 12-h interval. All the rats were perfused 12 h after the last injection. Group I was used to determine the effect of sevoflurane on the proliferation of progenitor cells labeled before anesthesia. Group II targeted the proliferation of progenitor cells that were in the S-phase of the cell cycle during the time of anesthesia. Group III was used to determine its effect after 4 days.
Immunohistochemistry Animals were deeply
anesthetized with 10% chloral hydrate (360 mg/kg, i. 
Fluoro-Jade (FJ) staining Sections of P7 rat brain
were mounted on glass slides and covered in 100% ethanol 
Real-time quantitative polymerase chain reaction (qPCR)
Twelve hours after sevoflurane anesthesia, the rat pups were decapitated and the brains harvested.
The DG area was selected. Total RNA was extracted using
TRIzol reagent (Invitrogen). RNA was reverse transcribed to cDNA using the Qiagen Omniscript RT kit (Qiagen, Valencia, CA) following the manufacturer's instructions. qPCR was performed for quantification of ki-67 and β-actin mRNA on a Rotor-Gene 3000 (Corbett Research, Sydney, Australia) based on the published methods [20, 21] . Changes in gene expression were determined using the ΔΔCt method [22] . β-actin was used as 
Western blot
The harvested DG samples were subjected to Western blot as described by Xie et al. [23] . Briefly, The signal of the Western blot band was detected using the Molecular Imager VersaDoc MP 5000 System (Bio-Rad).
The signal intensity was analyzed using a Bio-Rad image program (Quantity One) and ImageJ version 1.37 (National Institutes of Health, Bethesda, MD).
Morris water maze (MWM) test A black circular
tank (160 cm in diameter, 60 cm deep) was filled with water (21 ± 1°C) to a depth of 32 cm. The tank was surrounded by several visual cues. The animals were subjected to the MWM test twice: once at 2 weeks and once at 6 weeks after anesthesia. Each animal was tested for 6 consecutive days during each of the MWM tests. Briefly, a platform (9 × 9 cm 2 ) was submerged 0.5 cm below the water surface in the middle of one of the four virtual quadrants. Each day the animals were lowered into the water facing the wall from four different starting points. For example, if the goal was SE, then the start locations were N, W, NE or SW. Although not equidistant from the goal, these start positions are closer to being equal in length than using start positions adjacent to the goal. Animals that did not find the escape platform within 60 s were placed onto it by the researcher.
All rats were allowed to remain on the platform for 10s
for orientation and were then removed to rest for 15 s in a cage until the next trial. In each trial, the escape latency to reach the platform was measured by a computerized tracking system (Shanghai Jiliang Software Technology Co., Ltd., China). The four daily trials were averaged for each animal. On day 7, the escape platform was removed and the time spent in each quadrant during a single 60-s trial and the number of platform-site crossings were recorded.
Data analysis
Data are expressed as mean ± SEM.
Two-group comparisons were evaluated using Student's t-test. Multiple comparisons were evaluated by ANOVA followed by Dunnett's or Tukey's test. Differences were considered statistically significant for P <0.05.
Results
Blood gas analysis
There was no significant difference between the two groups in PH (sevoflurane 7.403 ± 0.004 versus control 7.403 ± 0.011; P >0.05, n = 6), pO 2 (37.83 ± 2.845 versus 41.50 ± 3.998 mmHg; P >0.05, n = 6) or pCO 2 (41.00 ± 1.487 versus 42.67 ± 2.115 mmHg; P > 0.05, n = 6).
Sevoflurane induces neuronal degeneration in DG
FJ staining was performed to detect neuronal cell death in the DG area [24, 25] . FJ is an anionic X fluorescein derivative which is used to stain degenerating neurons. This technique was originally developed by Schmued et al. [26] to 61.6 ± 1.5; P <0.05, n = 6) ( Fig. 1A-C) .
Caspase-3 activation is one of the final steps in apoptosis [27] . Therefore, we next assessed the effects of sevoflurane on caspase-3 activation in the DG area of P7 rats by
Western blot analysis after animal recovery from anesthe- 
sia. Caspase-3 immunoblotting showed visible increases
in the protein levels of cleaved caspase-3 after sevoflurane compared with the control condition (Fig. 1D) . Quantification of the Western blots, by determining the ratio of the cleaved (activated) caspase-3 fragment (17-20 kDa) to β-actin (42 kDa), revealed that anesthesia led to a >50% increase in caspase-3 activation after 4 h of anesthesia compared with the control condition. Taken together, these results suggest that sevoflurane causes significant neuronal degeneration in the DG of P7 rats and this effect lasts for at least 4 days.
Sevoflurane interferes with neurogenesis in DG
Since abnormal neurogenesis in the DG region has been suggested as a candidate mechanism for anesthesia-induced long-term neurocognitive dysfunction [28] , we next sought to determine the effect of sevoflurane on neurogenesis in P7 rat pups. First, we measured the mRNA level of Ki-67.
The Ki-67 protein (also known as MKI67) is a cellular marker strictly associated with proliferation [29] . During interphase, the Ki-67 antigen is exclusively detected within the nucleus, whereas in mitosis most of the protein is relocated to the surface of the chromosomes. Ki-67 protein is present during all active phases of the cell cycle (G1, S, G2, and mitosis), but is absent from resting cells (G0).The DG Ki-67 mRNA level was reduced by ~70% in sevoflurane-treated rats compared to control rats (Fig. 2E) . BrdU was administered to P7 pups 4 h before the scheduled sevoflurane anesthesia as a control experiment, since this dose of BrdU is availabile for <4 h [30] . In this group, we did not observe any difference in the number of BrdUpositive cells per DG between the control and sevofluranetreated groups ( Fig. 2A, B ) (BrdU Fig. 2A, C) , which indicated that sevoflurane has a negative effect on prolif eration during anesthetic action.
Third, we applied BrdU 4 days after sevoflurane administration. Interestingly, the proliferation was still inhibited in the sevoflurane-treated group (BrdU + cells/DG: control 28480 ± 1050 versus sevoflurane 14120 ± 902; P <0.05, n = 6; Fig. 2A, D) . Collectively, these results showed that sevoflurane inhibits neuronal proliferation in the DG region of P7 rats upon the administration of anesthesia and this effect lasts for at least 4 days.
Sevoflurane induces delayed-onset neurocognitive
deficits as measured by water maze spatial reference learning and memory retention tasks Both the sevoflurane and the control groups learned at a steady but slow rate when spatial reference memory was tested in the MWM on postnatal days 21-26 after 4 h of sevoflurane on P7. At 2 weeks after anesthesia, there was no difference between groups in the performance of either the cued trials, in which the platform was hidden, or the probe trial, in which the platform was removed from the tank (Fig. 3A,   B ).
When the same animals were retested 6 weeks after the anesthesia, rats that had received sevoflurane at P7 spent significantly more time searching for the platform in the target quadrant during the cued trials. At the end of the cued trials, the two groups performed the same (Fig. 3C , E-J). There was no difference in platform-site crossings between the two groups on the probe trial (Fig. 3D ).
Discussion
In this study, we reported for the first time that neonatally-administered sevoflurane induced deficits in hippocampus-dependent learning and memory in rats.
The impairment caused by sevoflurane was twofold: acute neuronal damage at the cellular level and a delayed-onset neurocognitive malfunction.
The DG develops in three distinct phases and the peak of neuronal expansion occurs around P7 [15] . In the P7 rat brain, the newly-formed DG is critical to the development of episodic memory [31] . Adequate and robust neurogenesis ensures hippocampal learning [32] , whereas decreased neurogenesis impairs it [16, 17] . Developing neurons from embryonic day 19 to P14 are most susceptible to anesthetic influences, as reported in several in vivo studies [33, 34] . In particular, the P7 rat is extremely sensitive to neurotoxic challenge [5] . Therefore, we chose P7 as the time point in our studies to administer anesthesia in order to evaluate sevoflurane-induced neurotoxic effects.
We first used FJ staining to assess the neuronal apoptosis induced by sevoflurane. FJ is in general comparable to silver staining [24, 25] . We found that just like isoflurane [35, 36] , sevoflurane significantly increased the numbers of FJpositive cells in the DG immediately after exposure, and that this effect was sustained for at least 4 days. Apoptosis was further confirmed by Western analysis of cleaved caspase-3. However, despite the clear signs of apoptosis,
we did not conclude that apoptosis is the only cause of the neurocognitive deficits shown by our MWM results. If apoptosis were the only cause, deficits should be evident immediately after the cell loss. But in our study, the MWM deficit occurred 6 weeks but not 2 weeks after sevoflurane application.
We next examined the effect of sevoflurane on DG neurogenesis, since disrupted neurogenesis in the DG region has been suggested as a candidate mechanism for anesthesia-induced long-term neurocognitive dysfunction [28] . We found that BrdU-positive cells in the DG in the anesthesia group were significantly fewer than in the control group both immediately after anesthesia and 4 days later. This indicates that neurogenesis in the DG was reduced by anesthesia, and that this effect lasted for at least 4
days. In addition, we performed qPCR to assess the mRNA level of Ki-67, which is a cell-cycle regulator gene. Sall et al. [37] showed that the Ki-67 mRNA level in cultured hippocampal neural precursor cells is significantly reduced by isoflurane exposure. Consistent with their findings, Ki-67 mRNA was also drastically decreased in the DG tissue from rat pups exposed to sevoflurane in our studies. Decreases in the number of BrdU + cells and the mRNA level of Ki-67 suggested that DG neurons in the experimental pups either were in growth phase arrest or had exited the cell cycle, as would occur with differentiation.
The MWM was chosen to evaluate the effect of sevoflurane on cognitive behavior in the rats since it is a reliable measure of hippocampus-dependent spatial navigation and reference memory [38] . Interestingly, we found that the learning curves of the rats that received sevoflurane or vehicle for 4 h on P7 were similar at P21. However, 6 weeks after anesthesia, the latencies shown by the rats receiving sevoflurane at P7 were significantly longer than those receiving vehicle. These results are consistent with the findings from other groups [13] . However, the uniqueness of our study is that there was no longer any difference in latency between the two groups at the end of the basic acquisition training. The probe test showed that the time spent in reaching the target quadrant was similar to the other quadrants. The numbers of platform-site crossings were also the same in the two groups. We interpret this to mean that the worsening of performance in the MWM caused by 4-h sevoflurane in P7 rats developed progressively so that no deficit was observed at 2 weeks but the deficit was evident at 6 weeks after anesthesia. However, what caused this delay in the onset of the cognitive deficit? As we noted previously, it is unlikely that cell death is the only consequence of anesthesia that contributes to this cognitive deficit. As shown by Keith et al., the hippocampal deficit caused by cell death alone in the DG indeed improves over 6 weeks [28] .
Both the type of deficit caused by sevoflurane and its onset between 2 and 6 weeks suggest that the decrease in neurogenesis may be the key mechanism. Decreased proliferation in neonates could lead to cognitive dysfunction by permanently disrupting the architecture of the hippocampus during a critical period of development or by depleting the pool of precursor cells present for the duration of the animal's life [37] . In our study, we found no difference between control and sevoflurane groups in the MWM at 2 weeks after anesthesia. Although the latency shown by the rats receiving sevoflurane was significantly longer than the controls when tested 6 weeks after anesthesia, they managed to catch up with the controls after 5 days of training, and the performance of both groups in the probe trial was comparable. These suggest that the long-term memory impaired by sevoflurane can be retrieved by training, in other words, stimulation.
Environmental stimuli may either enhance [39] or suppress [40] stem/progenitor cell proliferation, depending on the relative predominance of enriching or noxious qualities [41] . Anesthesia may alter the environmental stimuli, including neuronal signaling, and have age-dependent effects on cell proliferation in the DG [13] . It is possible that the retrieval of hippocampal learning after training is because the adult hippocampus integrates new neurons into its circuitry with learning [42, 43] . It should be noted that we did not assess the progenitor proliferation and degeneration beyond any time point after 4 days post-anesthesia. It is also not known whether the cognitive function would improve or deteriorate after 6 weeks post-anesthesia. Further studies are needed to address these concerns.
In summary, our study showed that sevoflurane significantly inhibited progenitor cell proliferation and enhanced degeneration in developing brain, and these effects led to subtle, progressive deficits in hippocampal-dependent learning and memory. Further studies are needed to determine whether the decreased proliferation is due to exit from the cell cycle or cellular differentiation. In addition, how sevoflurane affects the shaping of synapses in the DG is of great interest.
